2. Academic Validation
  3. Lenalidomide induces degradation of IKZF1 and IKZF3

Lenalidomide induces degradation of IKZF1 and IKZF3

  • Oncoimmunology. 2014 Jul 3;3(7):e941742. doi: 10.4161/21624011.2014.941742.
Jan Krönke 1,  Slater N Hurst 1,  Benjamin L Ebert 1
Affiliations

Affiliation

  • 1 Brigham and Women's Hospital ; Boston, MA USA.
PMID: 25610725 DOI: 10.4161/21624011.2014.941742
Abstract

Lenalidomide and its analogs, thalidomide and pomalidomide, specifically inhibit growth of mature B-cell lymphomas, including multiple myeloma, and induce interleukin-2 (IL-2) release from T cells. We recently found that this results from activation of the CRBN-CRL4 E3 ubiquitin Ligase to degrade the lymphoid transcription factors IKZF1 (Ikaros) and IKZF3 (Aiolos).

Keywords

lenalidomide; pomalidomide; thalidomide; ubiquitin.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z